Structural analysis of gene marker loci on chromosomes 10 and 11 in primary and secondary uraemic hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 13, Issue 2, 1998, Pages 350-357

  Inagaki, Chiho ^a   Dousseau, Mireille ^a   Pacher, Nathalie ^a   Sarfati, Emile ^b   Drüeke, Tilman B ^a   Gogusev, Jean ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Allelic loss; Chronic renal failure; Fluorescence in situ hybridization (FISH); Ha ras; Haemodialysis; Hyperparathyroidism; PRAD1; Primary; Rearrangement; RET; Secondary; Southern blot; WT1

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 10; CHROMOSOME 11; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; GENE LOCUS; GENE REARRANGEMENT; GENE STRUCTURE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARKER GENE; MONOSOMY; PARATHYROID GLAND; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SOUTHERN BLOTTING; UREMIA;

EID: 0031985790     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027829     Document Type: Article

References (45)

1. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 1988; 318: 658-662
2. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-2053
3. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Gene Chromosome Cane 1995; 13: 9-17
4. Arnold A, Kim HG. Clonal loss of one chromosome 11 in a parathyroid adenoma. J Clin Endocrinol Metab 1989; 69: 496-499
5. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 1996; 56: 599-605
6. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85-87
7. Morelli A, Falchetti A, Morosi A et al. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MENI patients. Biochem Biophys Res Commun 1996; 227: 736-742
8. Mulligan LM, Kwok JBJ, Healey CS et al. Germ-line mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460
9. Donis-Keller H, Dou S, Chi D et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 7: 851-856
10. Cryns VL, Thor A, Xu H-J et al. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 1994; 330: 757-761
11. Mole SE, Mulligan LM, Healey CS, Ponder BAJ, Tunacliffe A. Localization of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2. Hum Mol Genet 1993; 2: 247-252
12. Motokura T, Bloom T, Kim HG. A novel cyclin encoded by a bell-linked candidate oncogene. Nature 1991; 350: 512-515
13. Tabin CJ, Bradley SM, Bargmann CI et al. Mechanism of activation of a human oncogene. Nature 1982; 300: 143-149
14. Bell GI, Merrywealher JP, Sanchez-Pescador R et al. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984; 310: 775-777
15. Vasicek TJ, Mcdevitt BE, Freeman MW et al. Nucleotide sequence of the human parathyroid hormone gene. Proc Natl Acad Sci USA 1983; 80: 2127-2131
16. Call KM, Glaser T, Ito CY et al. Isolation and characterization of zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509-520
17. Takahashi M, Cooper GM. Ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Molec Cell Biol 1987; 7: 1378-1385
18. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13
19. Hopman AHN, Poddighe P, Moesker O, Ramaekers FCS. Interphase cytogenetics of solid tumors. In: Pollak JM, McGee JO (eds). In situ Hybridization: Principles and Practice. Oxford University Press, Oxford, 1989; 165
20. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, Jenkins RB. Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 1994; 152: 1157-1162
21. Taruscio D, Carcangiu ML, Ried T, Ward DC. Numerical chromosomal aberrations in thyroid tumors detected by fluorescence in situ hybridization. Gene Chromosome Cane 1983; 9: 180-185
22. Friedman E, Sakaguchi K., Bale AE et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 1989; 321; 213-218
23. Byström C, Larsson C, Blornberg C et al. Localization of the MEN1 gene to a small region within chromosome IIq13 by deletion mapping in tumors. Proc Natl Acad Sci USA 1990; 87: 1968-1972
24. Friedman E, Bale AE, Marx SJ et al. Genetic abnormalities in sporadic parathyroid adenomas. J Clin Endocrinol Metab 1990; 71:293-297
25. Thakker RV, Bouloux P, Wooding C et al. Association of parathyroid tumors in multiple endocrine neoplasia type I with loss of alleles on chromosome 11. N Engl J Med 1989; 321: 218-224
26. Beckers A, Abs R, Reyniers E et al. Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type 1 syndrome. J Clin Endocrinol Metab 1994; 79: 1498-1502
27. Lubensky IA, Delebenko LV, Zhuang ZP et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 1996; 56: 5272-5278
28. Brandi ML, Falchetti A, Tonelli F, Bordi C. (Editorial) Are allelic losses at 11q13 universal in MEN 1 tumors? J Clin Endocrinol Metab 1996; 81: 3162-3163
29. Tominaga Y, Kohara S, Namii Y et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996; 20: 744-752
30. Drüeke T. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. (Nephrology Forum.) Kidney Int 1995; 48: 259-272
31. Falchetti A, Bale AE, Amorosi A. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 1993; 76: 139-144
32. Tahara H, Smith AP, Gaz RD, Arnold A. Loss of chromosome arm 9p and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocrinol Metab 1996; 81: 3663-3667
33. Hollstein M, Sindransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53
34. Hakim JP, Levine MA. Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 1994; 78: 103-106
35. Cryns VL, Rubio M-P, Thor AD, Louis DN, Arnold A. p53 Abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 1320-1324
36. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580
37. 2+-sensing receptor gene cause familial hypocalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297-1303
38. Thompson DB, Samowitz WS, Odelberg S, Davis RK, Szabo J, Heath H III. Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab 1995; 80: 3377-3380
39. 2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 1995; 80: 3107-3110
40. Coppes MJ, Bonetta L, Huang A et al. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for non-disjunction or mitotic recombination. Gene Chromosome Canc 1992; 5: 326-334
41. Santoro M, Carlomagno F, Romano A et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 1995; 267: 381-383
42. Hofstra RMW, Landsvater RM, Ceccherini I et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994; 367: 375-376
43. Padberg B-C, Schröder S, Jochum W et al. Absence of RET proto-oncogene point mutation in sporadic hyperplastic and neoplastic lesion of the parathyroid gland. Am J Pathol 1995; 147: 1600-1607
44. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991; 6: 449-453
45. Hsi ED, Zukerberg LR, Yang W-I, Arnold A. CyclinD1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 1996; 81: 1736-1739